Author

J. C. Urcuyo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:imaging· 3 Approach:statistical model· 3 Research Focus:cell type annotation· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

K. R. Swanson· 3 shared A. Hawkins-Daarud· 2 shared J. N. Sarkaria· 2 shared S. C. Massey· 2 shared A. R. A. Anderson· 1 shared B. M. Marin· 1 shared B. R. Bendok· 1 shared B.-M. Marin· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

K. R. Swanson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mapping multiregional imaging-localized biopsies to MRI habitats reveals biologically significant glioma tissue states and associated patterns of cohabitating cellular subpopulations

L. Curtin, K. M. Bond, P. R. Jackson, A. Hawkins-Daarud, S. Velez, N. Shakir, J. C. Urcuyo, G. De Leon, K. W. Singleton, J. M. Langworthy, K. Clark-Swanson, Y. Lassiter-Morris, L. Paulson, C. Sereduk, C. Krishna, , K. R. Swanson

The paper maps MRI-localized glioma biopsies to MRI habitats, identifying transcriptional tissue states and their association with cellular subpopulations and MRI features.

bioRxiv · Mar 23, 2022 · PreprintCancer Biology

Complementary role of mathematical modeling in preclinical glioblastoma: differentiating poor drug delivery from drug insensitivity

J. C. Urcuyo, S. C. Massey, A. Hawkins-Daarud, B.-M. Marin, D. M. Burgenske, J. N. Sarkaria, K. R. Swanson

This paper uses mathematical modeling to differentiate between drug insensitivity and poor drug delivery in glioblastoma PDX models, validated by experimental results.

bioRxiv · Dec 7, 2021 · PreprintCancer Biology

Quantifying glioblastoma drug response dynamics incorporating resistance and blood brain barrier penetrance from experimental data

S. C. Massey, J. C. Urcuyo, B. M. Marin, J. N. Sarkaria, K. R. Swanson

The paper develops a mathematical model to quantify glioblastoma drug response dynamics, finding that BBB permeability may slightly outweigh drug resistance in therapeutic efficacy.

bioRxiv · Oct 29, 2019Cancer Biology